Filing Flows › cbdMD (YCBD) › Q3 FY26 › vs Q3 FY25
cbdMD (YCBD) Q3 FY26 vs Q3 FY25 (year over year)
cbdMD's revenue rose $947K (+21%) from $4.6M in Q3 FY25 to $5.6M in Q3 FY26.
cbdMD, Q3 FY26: revenue $5.6M (+21% year over year), operating margin -20.4%, net loss $1.1M, operating cash flow −$442K. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $5.6M | $4.6M | $947K | +21% |
| Net loss | $1.1M | $895K | $232K | +26% |
| Costs & expenses | $6.7M | $5.5M | $1.2M | +21% |
| Operating costs | $6.7M | $5.5M | $1.2M | +21% |
| Cost of revenue | $2.5M | $1.8M | $740K | +42% |
| Operating expenses | $4.2M | $3.7M | $432K | +12% |
| Operating cash sources | $1.1M | $895K | $232K | +26% |
| Depreciation & amortization | $259K | $280K | −$21K | -8% |
| Working capital & other | $426K | −$89K | $515K | — |
| Cash used in operations | $442K | $704K | −$262K | -37% |
| Net loss absorbed | $1.1M | $895K | $232K | +26% |
Questions
How much did cbdMD's revenue grow year over year in Q3 FY26?
cbdMD's revenue rose $947K (+21%) from $4.6M in Q3 FY25 to $5.6M in Q3 FY26.